Pharmacogenomics of hortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMIM, as novel high-risk feature in myeloma treated with Total Therapy 3

查看全文 作　　者：Shaughnessy JD Jr; Qu P; Usmani S; 出　　处：《Blood》索引2011年第118卷第13期,共0页